- AdventHealth
One year ago (March 2022), AdventHealth opened its first Post-COVID Clinic (PCC) to address clinical care for patients with long COVID and support COVID-related research.
Richard E. Pratley, M.D., medical director of the AdventHealth Diabetes Institute and senior scientist in diabetes research at the AdventHealth Translational Research Institute, and Dwayne Gordon, M.D., internal medicine physician with the AdventHealth Medical Group and lead physician at the PCC, recently appeared on the American Hospital Association’s Advancing Health podcast to discuss the improvements in patient outcomes and why investing in research and sharing collective experiences is key to minimizing COVID’s hold on the global community.
The Big Picture:
As the health care community evolves from pandemic to endemic, many hospitals are realizing the need for multidisciplinary clinics, like the AdventHealth model.
Successful Patient Outcomes:
Kathy Fennimore, 62, was the first patient to “graduate” from the clinic after six months of treatments and various therapies. She came into the clinic dependent on supplemental oxygen 24/7. The virus had exacerbated the pulmonary fibrosis, hypertension and autoimmune disease she’d been dealing with most of her life. She could barely walk 5-10 feet and couldn’t finish a six-minute walking test. Thanks to the care and treatment protocols at the PCC, she's now off oxygen, back at work, and is walking two to three miles a day.
Why we should pursue long COVID clinics...
Why research matters:
Scientists understand what COVID is and how it affects people but are still learning why symptoms occur and vary from patient-to-patient. Investigating the “why” through research is the path to determining better treatments.
Pre-pandemic, researchers at the AdventHealth Translational Research Institute were leading a multitude of research studies in metabolism, diabetes, and more – all of which had to essentially shut down (with the exception of very critical trials) in light of the clinical response to the pandemic.
Now, AdventHealth has entered a new phase where the focus is on better understanding long COVID.
Why investing in COVID research is key...
About the PCC:
The PCC currently has limited capacity, but a phased expansion is planned.
If you are a physician and have patients that may be a candidate for the PCC, email CFD.PostCOVIDClinic@adventhealth.com the patient’s name and contact information, as well as your name and contact information, and the PCC will follow-up to determine if the patient is qualified.
If you are a patient requesting more information or would like to see if you qualify for the PCC, please email CFD.PostCOVIDClinic@adventhealth.com. Please note a referral is required from your primary care physician.
To listen to the full AHA podcast featuring Dr. Pratley and Dr. Gordon, click here.
In addition to the PCC in Central Florida, AdventHealth has another long COVID clinic on Florida’s west coast at AdventHealth Tampa which focuses on pulmonary issues.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...